Cancer loves a lot of things: love, friends, a nice house, and money.
But the real love is money.
That’s because a cancer patient’s health insurance pays for the costs of treatment, according to the Cancer Treatment Industry Association, a trade group representing more than 5,000 doctors, nurses and hospitals.
For the next few years, that will pay for the full cost of treatments, which include hospitalization and the medications they need.
That money will come from the $6.3 billion Medicare program for low-income seniors, the money that is slated to go to Medicare Advantage health plans next year.
The group estimates that for every $1.05 of cancer-related spending that goes into the Medicare program, Medicare is projected to save about $3.25 in costs.
That savings is projected in a separate Medicare budget estimate.
The idea of paying for treatments comes up frequently in the media and among doctors and nurses.
The Medicare program pays for about 85% of all medical expenses.
But there is little to no data on the extent to which cancer patients pay for those costs.
There are a number of studies on how cancer patients spend their own money.
There is a lot more research out there about the costs that people pay, and there is a reason why the federal government pays the majority of that research and development, said David Gorman, a professor of economics at the University of Southern California.
The Affordable Care Act, or Obamacare, requires insurers to cover all types of medical care, including cancer treatments.
But it does not require the insurance companies to do so.
A key difference between the Affordable Care for All Act and the Medicare plan is that Obamacare also mandates that Medicare plans cover the cost of all drugs and tests and diagnostic tests for a set period of time, or until they are no longer needed.
It also requires that insurers cover certain types of treatments that are not covered by Medicare, such as surgery and radiotherapy.
Those costs are not included in Medicare’s calculations for how much patients spend, and are therefore not included as part of the program’s overall cost.
“It’s a significant change in how the government pays for health care,” said Scott Ghezzi, a senior analyst with the Kaiser Family Foundation.
The new Medicare budget estimates don’t take into account a set of medical conditions that are covered under Medicare Advantage plans.
That would likely reduce the amount of money that patients could be expected to pay for cancer treatments in the future.
The Congressional Budget Office, an independent agency, estimates that Medicare’s health care spending is $1 trillion a year, or about 5% of GDP.
And that number includes Medicare Advantage enrollees who don’t have to pay anything out of pocket.
The American Cancer Society estimated that if cancer treatment costs were included in the Medicare budget, it would bring the cost down to $1,800 per person annually.
That estimate was based on an average of 10 years of data, Ghezzi said.
There’s no way to know for sure what the future cost of cancer treatment would be, because the Medicare estimates rely on the government’s own estimates of how much cancer treatment patients would pay, he said.
Medicare’s estimate is based on estimates from its own actuaries, not the costs Medicare has paid for medical services in the past.
But some doctors and researchers have speculated that some cancer patients might pay more for their cancer treatment, even though they don’t receive any government support.
For instance, in the 1990s, the Medicare Part D program, which was used to pay cancer treatment for people over 65, allowed people to pay a fixed amount to the program, but that did not include costs like hospitalizations or drugs.
“I’ve been paying Medicare for the past 30 years, and I’ve never seen anyone get sick from Medicare Part 1,” said Dr. Anthony Scholes, who was the chief medical officer of a small medical practice in Atlanta and is now a consultant in New York.
“We had no Medicare Part 2,” he said, referring to the Medicare Advantage program that replaced Medicare.
Medicare Part C, which covers Medicare patients 65 and older, is also not included.
“Medicare Part C was never designed to cover cancer, and the reason it wasn’t was that we didn’t have any data to say that cancer was covered by Part C,” Scholes said.
That led to the idea of a new Medicare plan that would include both Medicare Part I and Part D, Scholes added.
But not everyone agrees with that idea.
“This Medicare system is not the way to pay the bills,” said Bruce Levenson, a health policy expert at the Center for American Progress.
Medicare, by design, doesn’t cover the full costs of cancer treatments because the government does not include them in its cost estimates.
Instead, the government relies on insurance companies, Medicare Advantage and other health plans to cover some costs.
The Centers for Medicare and Medicaid Services, which oversees Medicare, has estimated that the Medicare benefits program would pay for about 25% of costs of care for a